Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection

被引：3

作者：

Suren, Elcin ^{[1
]}

Cetinkaya, Ersan ^{[1
]}

Kalayci, Mustafa ^{[1
]}

Ozkan, Sariye Elif Ozyazici ^{[2
]}

Kucuk, Mehmet Fatih ^{[1
]}

Erol, Muhammet Kazim ^{[1
]}

机构：

[1] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Ophthalmol, Antalya, Turkey

[2] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Pediat, Antalya, Turkey

来源：

CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE | 2020年 / 2020卷

关键词：

D O I：

10.1155/2020/8861435

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.

引用

页数：3

共 50 条

[1] Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
Vedantham, Vasumathy
INDIAN JOURNAL OF OPHTHALMOLOGY, 2019, 67 (06) : 884 - 888
[2] Noninfectious Endophthalmitis after Intravitreal Injection of Aflibercept
Kim, Chung Hwan
Shin, Ji Soo
Jeon, Chan Yang
Chang, Young Suk
Lee, Young Hoon
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (06): : 1018 - 1021
[3] The systemic antiangiogenic effect of intravitreal aflibercept injection in a mouse model of retinopathy of prematurity
Ichiyama, Yusuke
Obata, Shumpei
Saishin, Yoshitsugu
Sawada, Osamu
Kakinoki, Masashi
Sawada, Tomoko
Kubota, Yoshiaki
Ohji, Masahito
FASEB JOURNAL, 2021, 35 (03):
[4] Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: A case report
Wang, Jianxun
Xiang, Daoman
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3563 - 3566
[5] COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB
Bavinger, J. Clay
Yu, Yinxi
Vanderbeek, Brian L.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (10): : 2004 - 2011
[6] Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity
Stahl, Andreas
Nakanishi, Hidehiko
Lepore, Domenico
Wu, Wei-Chi
Azuma, Noriyuki
Jacas, Carlos
Vitti, Robert
Athanikar, Aditya
Chu, Karen
Iveli, Pablo
Zhao, Fei
Leal, Sergio
Schlief, Sarah
Schmelter, Thomas
Miller, Thomas
Koefuencue, Evra
Fielder, Alistair
JAMA NETWORK OPEN, 2024, 7 (04)
[7] Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity
Huang, Chunling
Zou, Weikang
Ma, Wenbei
Li, Jiali
Bai, Yichen
Wu, Rong
Li, Qiqi
Fang, Qi
Chen, Wenna
Lu, Xiaohe
Feng, Songfu
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
[8] Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity
Huang, Chung-Ying
Lien, Reyin
Wang, Nan-Kai
Chao, An-Ning
Chen, Kuan-Jen
Chen, Tun-Lu
Hwang, Yih-Shiou
Lai, Chi-Chun
Wu, Wei-Chi
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (03) : 479 - 487
[9] Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity
Chung-Ying Huang
Reyin Lien
Nan-Kai Wang
An-Ning Chao
Kuan-Jen Chen
Tun-Lu Chen
Yih-Shiou Hwang
Chi-Chun Lai
Wei-Chi Wu
Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 479 - 487
[10] Intravitreal injection of bevacizumab for retinopathy of prematurity
Kuniyoshi, Kazuki
Sugioka, Koji
Sakuramoto, Hiroyuki
Kusaka, Shunji
Wada, Norihisa
Shimomura, Yoshikazu
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2014, 58 (03) : 237 - 243

← 1 2 3 4 5 →